TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,838.86−0.21%FTSE ADX9,857.97+0.76%TASI9,986.08−1.36%QE Index8,575.02−0.67%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,854.48−0.07%DFM:EMIRATESNBDAED 31.48−0.06%ADX:IHCAED 360.10+2.30%SAU:2222SAR 25.74−0.23%DSMD:QNBKQAR 15.49−1.09%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.15+0.23%Gold$4,124.67−0.39%Brent$110.48+1.15%BTC$81,444.44−0.49%ETH$2,387.73−0.73%DFM General5,838.86−0.21%FTSE ADX9,857.97+0.76%TASI9,986.08−1.36%QE Index8,575.02−0.67%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,854.48−0.07%DFM:EMIRATESNBDAED 31.48−0.06%ADX:IHCAED 360.10+2.30%SAU:2222SAR 25.74−0.23%DSMD:QNBKQAR 15.49−1.09%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.15+0.23%Gold$4,124.67−0.39%Brent$110.48+1.15%BTC$81,444.44−0.49%ETH$2,387.73−0.73%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralOpen 🇸🇦Saudi ArabiaTadawul · TASIOpen 🇶🇦QatarQSE · QE GeneralOpen 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Markets › United States › NAS › ARWR

A

Arrowhead Pharmaceuticals Inc

NAS:ARWRHealthcareNASDAQ:NBINASDAQ:NQUSMG

$57.23+2.38%At closeAt close · Tue 20 Oct · ≈ AED 210.18 · Market cap $8.08B · Next earnings Mon 30 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

Arrowhead Pharmaceuticals Inc · News · TradingHolo

ARWR news

Headlines tagged to this company

DOArrowhead Pharmaceuticals Price Target Maintained With a $115.00/Share by Chardan Capital

Dow Jones Newswires · 4 d ago

DOArrowhead Pharmaceuticals Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow Jones Newswires · 4 d ago

DOArrowhead Pharmaceuticals Price Target Raised to $109.00/Share From $63.00 by UBS

Dow Jones Newswires · 4 d ago

TRChardan Capital maintains Buy rating on Arrowhead Pharma, $115 price target

TradingView · 5 d ago

TRHC Wainwright & Co. reiterates Buy rating on Arrowhead Pharma, $120 price target

TradingView · 5 d ago

STArrowhead’s Alzheimer’s Drug Shows Sharp Reduction In Disease-Linked Protein In Early Trial – Here’s What Investors Need To Know

Stocktwits · 6 d ago

SEArrowhead spikes after early-stage trial data for Alzheimer’s disease

Seeking Alpha · 6 d ago

REArrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers

Reuters · 6 d ago

TRArrowhead Pharmaceuticals, Inc. (ARWR) Reports Up to 85% CSF Tau Reduction in Phase 1/2a

TradingView · 6 d ago

STStocktwits Pharma Pulse: JNJ Earnings, Cancer Updates And Two FDA Target Dates — The Week’s Biotech Watchlist

Stocktwits · 8 d ago

SECatalyst watch: Big bank earnings, CPI, and the Paris Auto Show

Seeking Alpha · 11 d ago

REArrowhead Pharmaceuticals Granted Entry In The FDA Star Pilot Program For Plozasiran In Severe Hypertriglyceridemia

Reuters · 13 d ago

TRArrowhead Pharmaceuticals, Inc. (ARWR) Plozasiran sNDA Accepted Into FDA STAR Program

TradingView · 13 d ago

SEThese healthcare stocks stand out with A+ growth grades

Seeking Alpha · 15 d ago

SEThese ten healthcare stocks posted the biggest one-month losses

Seeking Alpha · 19 d ago

BUArrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies

BusinessWire · 21 d ago

STARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near

stocktwits · 26 d ago

BENasdaq 100 Slips, 10-Year Yields Hit 19-Year Highs: Stock Market Today

benzinga · 27 d ago